CDMO Live-Signale | Maximieren Sie Profite mit Getagraph.com

VERKAUFEN 109331 min ago

@ $6.64

Ausgestellt: 13 Feb 2024 @ 21:43

Rendite: 15.06%

Vorheriges Signal: Feb 13 - 15:30

Vorheriges Signal: Kaufen

Rendite: -1.48 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 20:54):

Stats
Tagesvolumen	492 104
Durchschnittsvolumen	1.36M
Marktkapitalisierung	484.99M
EPS	$0 ( 2023-12-07 )
Nächstes Ertragsdatum	( $0 ) 2024-06-19
Last Dividend	$0.656 ( 2018-03-16 )
Next Dividend	$0 ( N/A )
P/E	-27.29
ATR14	$0.0110 (0.14%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-11	Kwietniak Matthew R.	Sell	669	Restricted Stock Units
2024-04-11	Kwietniak Matthew R.	Buy	669	Common Stock, $0.001 par value
2024-04-09	Ziebell Mark R	Buy	1 251	Common Stock, $0.001 par value
2024-04-09	Ziebell Mark R	Buy	1 261	Common Stock, $0.001 par value
2024-04-09	Ziebell Mark R	Buy	696	Common Stock, $0.001 par value

INSIDER POWER
41.05
Last 100 transactions
Buy: 323 693 \| Sell: 129 909

Volumen Korrelation

Lang: -0.06 (neutral)

Kurz: 0.08 (neutral)

Signal:(35.032) Neutral

Avid Bioservices Inc Korrelation

10 Am meisten positiv korreliert
EMLD	0.912
ARRW	0.911
FEXD	0.891
ESCA	0.891
CPAQ	0.89
FTAA	0.889
TWLV	0.888
ARDX	0.888
ABGI	0.884
NBST	0.883

10 Am meisten negativ korreliert
CUTR	-0.894
PEAR	-0.892
GRIN	-0.892
HRMY	-0.891
GCBC	-0.891
ORPH	-0.89
SRCE	-0.888
GSBC	-0.886
FCBC	-0.882
VORB	-0.879

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Avid Bioservices Inc Korrelation - Währung/Rohstoff

0.17
( neutral )

0.33
( neutral )

0.00
( neutral )

-0.30
( neutral )

0.70
( moderate )

-0.79
( moderate negative )

Avid Bioservices Inc Finanzdaten

Annual	2023
Umsatz:	$149.27M
Bruttogewinn:	$31.48M (21.09 %)
EPS:	$0.00900

FY	2023
Umsatz:	$149.27M
Bruttogewinn:	$31.48M (21.09 %)
EPS:	$0.00900

FY	2022
Umsatz:	$119.60M
Bruttogewinn:	$36.65M (30.64 %)
EPS:	$2.08

FY	2021
Umsatz:	$95.87M
Bruttogewinn:	$29.31M (30.57 %)
EPS:	$0.0600

Financial Reports:

No articles found.

Avid Bioservices Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Avid Bioservices Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0.0723 - No dividend growth expected in the near future

Information

First Dividend	$0.656	2018-03-16
Last Dividend	$0.656	2018-03-16
Next Dividend	$0	N/A
Payout Date	2018-04-02
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.656	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0.0723
Div. Directional Score	0	--

Next Divdend (Est)
(2024-04-29)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2018	$0.656	16.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.131	1.500	-2.62	-3.93	[0 - 0.5]
returnOnAssetsTTM	-0.0394	1.200	-1.312	-1.574	[0 - 0.3]
returnOnEquityTTM	-0.0963	1.500	-2.18	-3.27	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.465	0.800	-2.68	-2.14	[1 - 3]
quickRatioTTM	0.297	0.800	-2.96	-2.37	[0.8 - 2.5]
cashRatioTTM	0.138	1.500	-0.346	-0.519	[0.2 - 2]
debtRatioTTM	0.431	-1.500	2.81	-4.22	[0 - 0.6]
interestCoverageTTM	-10.85	1.000	-5.13	-5.13	[3 - 30]
operatingCashFlowPerShareTTM	0.194	2.00	9.94	10.00	[0 - 30]
freeCashFlowPerShareTTM	-0.608	2.00	-0.304	-0.608	[0 - 20]
debtEquityRatioTTM	1.090	-1.500	5.64	-8.46	[0 - 2.5]
grossProfitMarginTTM	0.0747	1.000	-2.09	-2.09	[0.2 - 0.8]
operatingProfitMarginTTM	-0.132	1.000	-4.64	-4.64	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0627	1.000	-0.763	-0.763	[0.2 - 2]
assetTurnoverTTM	0.300	0.800	-1.331	-1.065	[0.5 - 2]
Total Score				-0.942

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-25.98	1.000	-2.72	0	[1 - 100]
returnOnEquityTTM	-0.0963	2.50	-1.402	-3.27	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.608	2.00	-0.203	-0.608	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.194	2.00	9.94	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.261	1.500	-1.594	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0900	1.000	-0.250	0	[0.1 - 0.5]
Total Score				0.0723

Avid Bioservices Inc

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Echtzeitaktualisierungen für Avid Bioservices Inc [CDMO]

Upcoming Earnings Alert

Avid Bioservices Inc Dividend Information - No Dividend Player

Dividend Commentary

Top 10 dividend Companies for NASDAQ

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)